ArticleScientific reports2018

Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.

Sami Mamand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.